Bionxt Solutions Inc (BNXTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | ||
| Net Income | -1,306 | -660 |
| Depreciation Amortization | 331 | 157 |
| Accounts receivable | 53 | -14 |
| Accounts payable and accrued liabilities | -173 | -50 |
| Other Working Capital | -194 | -109 |
| Other Operating Activity | 290 | 138 |
| Operating Cash Flow | $-999 | $-538 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -30 | -24 |
| Purchase Sale Intangibles | -4 | N/A |
| Other Investing Activity | -4 | 0 |
| Investing Cash Flow | $-34 | $-24 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 607 | 380 |
| Other Financing Activity | 255 | 440 |
| Financing Cash Flow | $862 | $820 |
| Beginning Cash Position | 1,769 | 1,780 |
| End Cash Position | 1,598 | 2,038 |
| Net Cash Flow | $-171 | $258 |
| Free Cash Flow | ||
| Operating Cash Flow | -999 | -538 |
| Capital Expenditure | -30 | -24 |
| Free Cash Flow | -1,029 | -562 |